4′-Thionucleosides as Potent and Selective A3 Adenosine Receptor Ligands

被引:0
|
作者
Sahu, Pramod K. [1 ]
Naik, Siddhi D. [1 ,2 ]
Mehdi, Sofia [1 ]
Jeong, Lak S. [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[2] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
基金
新加坡国家研究基金会;
关键词
A(3) adenosine receptor; agonist; antagonist; 4 '-thionucleoside; structure-activity relationship; CL-IB-MECA; CELL-CYCLE ARREST; HIGHLY POTENT; CANCER CELLS; AGONIST; DERIVATIVES; ANTAGONISTS; APOPTOSIS; DESIGN; D-4'-THIOADENOSINE;
D O I
10.2174/1385272819666150804000511
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A(3) adenosine receptors (ARs) have long been viewed as potential therapeutic targets due to their association with a variety of pathophysiological processes. Development of potent and selective A(3)AR nucleoside ligands has been an area of interest of medicinal chemists since last two decades. Various prime modifications made on N-6 and C-2 position of the adenosine moiety has led to the discovery of some of the most efficacious A3AR ligands. This review is an account of the development of 4'-thionucleosides as A(3)AR agonists and antagonists by various chemical modifications on the thionucleoside template.
引用
收藏
页码:930 / 938
页数:9
相关论文
共 50 条
  • [31] DISCOVERY OF STRUCTURALLY SIMPLE, HIGHLY POTENT AND SELECTIVE A3 ADENOSINE ANTAGONISTS
    Yaziji, Vicente
    Coelho, Alberto
    Brea, Jose
    Isabel Loza, M.
    Gutierrez-de-Teran, Hugo
    Rodriguez, David
    Sotelo, Eddy
    DRUGS OF THE FUTURE, 2009, 34 : 178 - 178
  • [32] Reversine and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists
    Perreira, M
    Jiang, JK
    Klutz, AM
    Gao, ZG
    Shainberg, A
    Lu, CR
    Thomas, CJ
    Jacobson, KA
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) : 4910 - 4918
  • [33] The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles
    Mogensen, JP
    Roberts, SM
    Bowler, AN
    Thomsen, C
    Knutsen, LJS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (13) : 1767 - 1770
  • [34] N6-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A3 receptor and a starting point for searching A2B ligands
    Volpini, R
    Costanzi, S
    Lambertucci, C
    Taffi, S
    Vittori, S
    Klotz, KN
    Cristalli, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (15) : 3271 - 3279
  • [35] 1,2,4-triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A3 receptor ligands
    Okamura, T
    Kurogi, Y
    Nishikawa, H
    Hashimoto, K
    Fujiwara, H
    Nagao, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) : 3703 - 3708
  • [36] New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists
    Baraldi, PG
    Tabrizi, MA
    Preti, D
    Bovero, A
    Fruttarolo, F
    Romagnoli, R
    Zaid, NA
    Moorman, AR
    Varani, K
    Borea, PA
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) : 5001 - 5008
  • [37] Functionalized congeners of A3 adenosine receptor-selective nucleosides
    Tosh, Dilip K.
    Chinn, Moshe
    Ivanov, Andrei A.
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [38] Discovery of novel A3 adenosine receptor ligands based on chromone scaffold
    Gaspar, Alexandra
    Reis, Joana
    Kachler, Sonja
    Paoletta, Silvia
    Uriarte, Eugenio
    Klotz, Karl-Norbert
    Moro, Stefano
    Borges, Fernanda
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (01) : 21 - 29
  • [39] Potent and selective ligands for adenosine binding sites
    Cristalli, G
    Camaioni, E
    DiFrancesco, E
    Eleuteri, A
    Vittori, S
    Volpini, R
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 1379 - 1388
  • [40] Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists
    Jung, KY
    Kim, SK
    Gao, ZG
    Gross, AS
    Melman, N
    Jacobson, KA
    Kim, YC
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (03) : 613 - 623